Global Liposome Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Liposome Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposome Drug Delivery Revenue 2016-2027
2.1.2 Global Liposome Drug Delivery Sales 2016-2027
2.2 Liposome Drug Delivery Market Size by Region: 2021 Versus 2027
2.3 Liposome Drug Delivery Sales by Region (2016-2027)
2.3.1 Global Liposome Drug Delivery Sales by Region: 2016-2021
2.3.2 Global Liposome Drug Delivery Sales Forecast by Region (2022-2027)
2.3.3 Global Liposome Drug Delivery Sales Market Share by Region (2016-2027)
2.4 Liposome Drug Delivery Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Liposome Drug Delivery Revenue by Region: 2016-2021
2.4.2 Global Liposome Drug Delivery Revenue Forecast by Region (2022-2027)
2.4.3 Global Liposome Drug Delivery Revenue Market Share by Region (2016-2027)
3 Global Liposome Drug Delivery by Manufacturers
3.1 Global Top Liposome Drug Delivery Manufacturers by Sales
3.1.1 Global Liposome Drug Delivery Sales by Manufacturer (2016-2021)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Liposome Drug Delivery Manufacturers by Revenue
3.2.1 Global Liposome Drug Delivery Revenue by Manufacturer (2016-2021)
3.2.2 Global Liposome Drug Delivery Revenue Share by Manufacturer (2016-2021)
3.3 Global Liposome Drug Delivery Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Liposome Drug Delivery Manufacturers Covered: Ranking by Revenue
3.4.2 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Liposome Drug Delivery Manufacturing Base Distribution, Product Type
3.5.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Liposome Drug Delivery Product Type
3.5.3 Date of International Manufacturers Enter into Liposome Drug Delivery Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Gilead Sciences
4.1.1 Gilead Sciences Corporation Information
4.1.2 Gilead Sciences Description, Business Overview
4.1.3 Gilead Sciences Liposome Drug Delivery Products Offered
4.1.4 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Gilead Sciences Liposome Drug Delivery Revenue by Product
4.1.6 Gilead Sciences Liposome Drug Delivery Revenue by Application
4.1.7 Gilead Sciences Liposome Drug Delivery Revenue by Geographic Area
4.1.8 Gilead Sciences Liposome Drug Delivery Revenue by Sales Channel
4.1.9 Gilead Sciences Recent Development
4.2 Pacira
4.2.1 Pacira Corporation Information
4.2.2 Pacira Description, Business Overview
4.2.3 Pacira Liposome Drug Delivery Products Offered
4.2.4 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Pacira Liposome Drug Delivery Revenue by Product
4.2.6 Pacira Liposome Drug Delivery Revenue by Application
4.2.7 Pacira Liposome Drug Delivery Revenue by Geographic Area
4.2.8 Pacira Liposome Drug Delivery Revenue by Sales Channel
4.2.9 Pacira Recent Development
4.3 Sun Pharmaceutical
4.3.1 Sun Pharmaceutical Corporation Information
4.3.2 Sun Pharmaceutical Description, Business Overview
4.3.3 Sun Pharmaceutical Liposome Drug Delivery Products Offered
4.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Sun Pharmaceutical Liposome Drug Delivery Revenue by Product
4.3.6 Sun Pharmaceutical Liposome Drug Delivery Revenue by Application
4.3.7 Sun Pharmaceutical Liposome Drug Delivery Revenue by Geographic Area
4.3.8 Sun Pharmaceutical Liposome Drug Delivery Revenue by Sales Channel
4.3.9 Sun Pharmaceutical Recent Development
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Corporation Information
4.4.2 Johnson & Johnson Description, Business Overview
4.4.3 Johnson & Johnson Liposome Drug Delivery Products Offered
4.4.4 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Johnson & Johnson Liposome Drug Delivery Revenue by Product
4.4.6 Johnson & Johnson Liposome Drug Delivery Revenue by Application
4.4.7 Johnson & Johnson Liposome Drug Delivery Revenue by Geographic Area
4.4.8 Johnson & Johnson Liposome Drug Delivery Revenue by Sales Channel
4.4.9 Johnson & Johnson Recent Development
4.5 Luye Pharma
4.5.1 Luye Pharma Corporation Information
4.5.2 Luye Pharma Description, Business Overview
4.5.3 Luye Pharma Liposome Drug Delivery Products Offered
4.5.4 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Luye Pharma Liposome Drug Delivery Revenue by Product
4.5.6 Luye Pharma Liposome Drug Delivery Revenue by Application
4.5.7 Luye Pharma Liposome Drug Delivery Revenue by Geographic Area
4.5.8 Luye Pharma Liposome Drug Delivery Revenue by Sales Channel
4.5.9 Luye Pharma Recent Development
4.6 Sigma-Tau
4.6.1 Sigma-Tau Corporation Information
4.6.2 Sigma-Tau Description, Business Overview
4.6.3 Sigma-Tau Liposome Drug Delivery Products Offered
4.6.4 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Sigma-Tau Liposome Drug Delivery Revenue by Product
4.6.6 Sigma-Tau Liposome Drug Delivery Revenue by Application
4.6.7 Sigma-Tau Liposome Drug Delivery Revenue by Geographic Area
4.6.8 Sigma-Tau Recent Development
4.7 Ipsen (Onivyde)
4.7.1 Ipsen (Onivyde) Corporation Information
4.7.2 Ipsen (Onivyde) Description, Business Overview
4.7.3 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
4.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Ipsen (Onivyde) Liposome Drug Delivery Revenue by Product
4.7.6 Ipsen (Onivyde) Liposome Drug Delivery Revenue by Application
4.7.7 Ipsen (Onivyde) Liposome Drug Delivery Revenue by Geographic Area
4.7.8 Ipsen (Onivyde) Recent Development
4.8 CSPC
4.8.1 CSPC Corporation Information
4.8.2 CSPC Description, Business Overview
4.8.3 CSPC Liposome Drug Delivery Products Offered
4.8.4 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.8.5 CSPC Liposome Drug Delivery Revenue by Product
4.8.6 CSPC Liposome Drug Delivery Revenue by Application
4.8.7 CSPC Liposome Drug Delivery Revenue by Geographic Area
4.8.8 CSPC Recent Development
4.9 Teva Pharmaceutical
4.9.1 Teva Pharmaceutical Corporation Information
4.9.2 Teva Pharmaceutical Description, Business Overview
4.9.3 Teva Pharmaceutical Liposome Drug Delivery Products Offered
4.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Teva Pharmaceutical Liposome Drug Delivery Revenue by Product
4.9.6 Teva Pharmaceutical Liposome Drug Delivery Revenue by Application
4.9.7 Teva Pharmaceutical Liposome Drug Delivery Revenue by Geographic Area
4.9.8 Teva Pharmaceutical Recent Development
4.10 Novartis
4.10.1 Novartis Corporation Information
4.10.2 Novartis Description, Business Overview
4.10.3 Novartis Liposome Drug Delivery Products Offered
4.10.4 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Novartis Liposome Drug Delivery Revenue by Product
4.10.6 Novartis Liposome Drug Delivery Revenue by Application
4.10.7 Novartis Liposome Drug Delivery Revenue by Geographic Area
4.10.8 Novartis Recent Development
4.11 Fudan-Zhangjiang
4.11.1 Fudan-Zhangjiang Corporation Information
4.11.2 Fudan-Zhangjiang Description, Business Overview
4.11.3 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
4.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Fudan-Zhangjiang Liposome Drug Delivery Revenue by Product
4.11.6 Fudan-Zhangjiang Liposome Drug Delivery Revenue by Application
4.11.7 Fudan-Zhangjiang Liposome Drug Delivery Revenue by Geographic Area
4.11.8 Fudan-Zhangjiang Recent Development
5 Breakdown Data by Type
5.1 Global Liposome Drug Delivery Sales by Type (2016-2027)
5.1.1 Global Liposome Drug Delivery Sales by Type (2016-2021)
5.1.2 Global Liposome Drug Delivery Sales Forecast by Type (2022-2027)
5.1.3 Global Liposome Drug Delivery Sales Market Share by Type (2016-2027)
5.2 Global Liposome Drug Delivery Revenue Forecast by Type (2016-2027)
5.2.1 Global Liposome Drug Delivery Revenue by Type (2016-2021)
5.2.2 Global Liposome Drug Delivery Revenue Forecast by Type (2022-2027)
5.2.3 Global Liposome Drug Delivery Revenue Market Share by Type (2016-2027)
5.3 Liposome Drug Delivery Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Liposome Drug Delivery Sales by Application (2016-2027)
6.1.1 Global Liposome Drug Delivery Sales by Application (2016-2021)
6.1.2 Global Liposome Drug Delivery Sales Forecast by Application (2022-2027)
6.1.3 Global Liposome Drug Delivery Sales Market Share by Application (2016-2027)
6.2 Global Liposome Drug Delivery Revenue Forecast by Application (2016-2027)
6.2.1 Global Liposome Drug Delivery Revenue by Application (2016-2021)
6.2.2 Global Liposome Drug Delivery Revenue Forecast by Application (2022-2027)
6.2.3 Global Liposome Drug Delivery Revenue Market Share by Application (2016-2027)
6.3 Liposome Drug Delivery Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Liposome Drug Delivery Market Size YoY Growth 2016-2027
7.2 North America Liposome Drug Delivery Market Facts & Figures by Country
7.2.1 North America Liposome Drug Delivery Sales by Country (2016-2027)
7.2.2 North America Liposome Drug Delivery Revenue by Country (2016-2027)
7.3 North America Liposome Drug Delivery Sales by Type
7.4 North America Liposome Drug Delivery Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Liposome Drug Delivery Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Liposome Drug Delivery Market Facts & Figures by Region
8.2.1 Asia-Pacific Liposome Drug Delivery Sales by Region (2016-2027)
8.2.2 Asia-Pacific Liposome Drug Delivery Revenue by Region (2016-2027)
8.3 Asia-Pacific Liposome Drug Delivery Sales by Type
8.4 Asia-Pacific Liposome Drug Delivery Sales by Application
9 Europe
9.1 Europe Liposome Drug Delivery Market Size YoY Growth 2016-2027
9.2 Europe Liposome Drug Delivery Market Facts & Figures by Country
9.2.1 Europe Liposome Drug Delivery Sales by Country (2016-2027)
9.2.2 Europe Liposome Drug Delivery Revenue by Country (2016-2027)
9.3 Europe Liposome Drug Delivery Sales by Type
9.4 Europe Liposome Drug Delivery Sales by Application
10 Latin America
10.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2016-2027
10.2 Latin America Liposome Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Liposome Drug Delivery Sales by Country (2016-2027)
10.2.2 Latin America Liposome Drug Delivery Revenue by Country (2016-2027)
10.3 Latin America Liposome Drug Delivery Sales by Type
10.4 Latin America Liposome Drug Delivery Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Liposome Drug Delivery Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2016-2027)
11.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2016-2027)
11.3 Middle East and Africa Liposome Drug Delivery Sales by Type
11.4 Middle East and Africa Liposome Drug Delivery Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Liposome Drug Delivery Supply Chain Analysis
12.2 Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
12.3 Liposome Drug Delivery Clients Analysis
12.4 Liposome Drug Delivery Sales Channel and Sales Model Analysis
12.4.1 Liposome Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Liposome Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Liposome Drug Delivery Distributors
13 Market Dynamics
13.1 Liposome Drug Delivery Market Drivers
13.2 Liposome Drug Delivery Market Opportunities
13.3 Liposome Drug Delivery Market Challenges
13.4 Liposome Drug Delivery Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Liposomal Doxorubicin
Table 3. Major Manufacturers of Liposomal Amphoteracin B
Table 4. Major Manufacturers of Liposomal Paclitaxel
Table 5. Major Manufacturers of Others
Table 6. Global Liposome Drug Delivery Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 7. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2021 VS 2027
Table 8. Global Liposome Drug Delivery Sales by Region (2016-2021) & (K Vial)
Table 9. Global Liposome Drug Delivery Sales Forecast by Region (2022-2027) & (K Vial)
Table 10. Global Liposome Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Liposome Drug Delivery Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Liposome Drug Delivery Sales by Manufacturer (2016-2021) & (K Vial)
Table 13. Global Liposome Drug Delivery Sales Share by Manufacturer (2016-2021)
Table 14. Liposome Drug Delivery Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 15. Liposome Drug Delivery Revenue Share by Manufacturer (2016-2021)
Table 16. Key Manufacturers Liposome Drug Delivery Price (2016-2021) & (USD/Vial)
Table 17. Ranking of Global Top Liposome Drug Delivery Manufacturers by Revenue (US$ Million) in 2020
Table 18. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2020)
Table 20. Liposome Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Liposome Drug Delivery Product Type
Table 22. Date of International Manufacturers Enter into Liposome Drug Delivery Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Gilead Sciences Corporation Information
Table 25. Gilead Sciences Description and Business Overview
Table 26. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 27. Gilead Sciences Liposome Drug Delivery Product
Table 28. Gilead Sciences Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 29. Gilead Sciences Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 30. Gilead Sciences Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 31. Gilead Sciences Liposome Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 32. Gilead Sciences Recent Development
Table 33. Pacira Corporation Information
Table 34. Pacira Description and Business Overview
Table 35. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 36. Pacira Liposome Drug Delivery Product
Table 37. Pacira Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 38. Pacira Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 39. Pacira Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Pacira Liposome Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Pacira Recent Development
Table 42. Sun Pharmaceutical Corporation Information
Table 43. Sun Pharmaceutical Description and Business Overview
Table 44. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 45. Sun Pharmaceutical Liposome Drug Delivery Product
Table 46. Sun Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 47. Sun Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 48. Sun Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Sun Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Sun Pharmaceutical Recent Development
Table 51. Johnson & Johnson Corporation Information
Table 52. Johnson & Johnson Description and Business Overview
Table 53. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 54. Johnson & Johnson Liposome Drug Delivery Product
Table 55. Johnson & Johnson Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 56. Johnson & Johnson Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 57. Johnson & Johnson Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Johnson & Johnson Liposome Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Johnson & Johnson Recent Development
Table 60. Luye Pharma Corporation Information
Table 61. Luye Pharma Description and Business Overview
Table 62. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 63. Luye Pharma Liposome Drug Delivery Product
Table 64. Luye Pharma Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 65. Luye Pharma Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 66. Luye Pharma Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Luye Pharma Liposome Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Luye Pharma Recent Development
Table 69. Sigma-Tau Corporation Information
Table 70. Sigma-Tau Description and Business Overview
Table 71. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 72. Sigma-Tau Liposome Drug Delivery Product
Table 73. Sigma-Tau Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 74. Sigma-Tau Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 75. Sigma-Tau Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 76. Sigma-Tau Recent Development
Table 77. Ipsen (Onivyde) Corporation Information
Table 78. Ipsen (Onivyde) Description and Business Overview
Table 79. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 80. Ipsen (Onivyde) Liposome Drug Delivery Product
Table 81. Ipsen (Onivyde) Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 82. Ipsen (Onivyde) Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 83. Ipsen (Onivyde) Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 84. Ipsen (Onivyde) Recent Development
Table 85. CSPC Corporation Information
Table 86. CSPC Description and Business Overview
Table 87. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 88. CSPC Liposome Drug Delivery Product
Table 89. CSPC Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 90. CSPC Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 91. CSPC Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 92. CSPC Recent Development
Table 93. Teva Pharmaceutical Corporation Information
Table 94. Teva Pharmaceutical Description and Business Overview
Table 95. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 96. Teva Pharmaceutical Liposome Drug Delivery Product
Table 97. Teva Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 98. Teva Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 99. Teva Pharmaceutical Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 100. Teva Pharmaceutical Recent Development
Table 101. Novartis Corporation Information
Table 102. Novartis Description and Business Overview
Table 103. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 104. Novartis Liposome Drug Delivery Product
Table 105. Novartis Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 106. Novartis Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 107. Novartis Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 108. Novartis Recent Development
Table 109. Fudan-Zhangjiang Corporation Information
Table 110. Fudan-Zhangjiang Description and Business Overview
Table 111. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 112. Fudan-Zhangjiang Liposome Drug Delivery Product
Table 113. Fudan-Zhangjiang Liposome Drug Delivery Revenue (US$ Million) and Market Share by Product
Table 114. Fudan-Zhangjiang Liposome Drug Delivery Revenue (US$ Million) and Market Share by Application
Table 115. Fudan-Zhangjiang Liposome Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area
Table 116. Fudan-Zhangjiang Recent Development
Table 117. Global Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 118. Global Liposome Drug Delivery Sales Forecast by Type (2022-2027) & (K Vial)
Table 119. Global Liposome Drug Delivery Revenue by Type (2016-2021) & (US$ Million)
Table 120. Global Liposome Drug Delivery Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 121. Global Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 122. Global Liposome Drug Delivery Sales Forecast by Application (2022-2027) & (K Vial)
Table 123. Global Liposome Drug Delivery Revenue by Application (2016-2021) & (US$ Million)
Table 124. Global Liposome Drug Delivery Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 125. North America Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 126. North America Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 127. North America Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 128. North America Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 129. North America Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 130. North America Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 131. Asia-Pacific Liposome Drug Delivery Sales by Region (2016-2021) & (K Vial)
Table 132. Asia-Pacific Liposome Drug Delivery Sales by Region (2022-2027) & (K Vial)
Table 133. Asia-Pacific Liposome Drug Delivery Revenue by Region (2016-2027) & (US$ Million)
Table 134. Asia-Pacific Liposome Drug Delivery Revenue by Region (2022-2027) & (US$ Million)
Table 135. Asia-Pacific Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 136. Asia-Pacific Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 137. Europe Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 138. Europe Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 139. Europe Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 140. Europe Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 141. Europe Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 142. Europe Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 143. Latin America Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 144. Latin America Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 145. Latin America Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 146. Latin America Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 147. Latin America Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 148. Latin America Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 149. Middle East and Africa Liposome Drug Delivery Sales by Country (2016-2021) & (K Vial)
Table 150. Middle East and Africa Liposome Drug Delivery Sales by Country (2022-2027) & (K Vial)
Table 151. Middle East and Africa Liposome Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 152. Middle East and Africa Liposome Drug Delivery Revenue by Country (2022-2027) & (US$ Million)
Table 153. Middle East and Africa Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 154. Middle East and Africa Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 155. Liposome Drug Delivery Key Raw Materials, Industry Status and Trend
Table 156. Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
Table 157. Liposome Drug Delivery Clients Status and Trend
Table 158. Liposome Drug Delivery Typical Clients
Table 159. Liposome Drug Delivery Distributors
Table 160. Key Drivers: Impact Analysis (2022-2027)
Table 161. Liposome Drug Delivery Market Drivers
Table 162. Liposome Drug Delivery Market Opportunities
Table 163. Liposome Drug Delivery Market Challenges
Table 164. Liposome Drug Delivery Market Restraints
Table 165. Liposome Drug Delivery Porter's Five Forces Analysis
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposome Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 8. Fungal Infection Therapy Examples
Figure 9. Cancer & Tumor Therapy Examples
Figure 10. Others Examples
Figure 11. Liposome Drug Delivery Report Years Considered
Figure 12. Global Liposome Drug Delivery Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Liposome Drug Delivery Market Size 2016-2027 (US$ Million)
Figure 14. Global Liposome Drug Delivery Sales 2016-2027 (K Units)
Figure 15. Global Liposome Drug Delivery Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2016-2027)
Figure 17. Global Liposome Drug Delivery Revenue Market Share by Region (2016-2027)
Figure 18. Global Liposome Drug Delivery Sales Share by Manufacturer in 2020
Figure 19. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2016-2027)
Figure 21. Global Liposome Drug Delivery Revenue Market Share Forecast by Type (2016-2027)
Figure 22. Liposome Drug Delivery Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 23. Global Liposome Drug Delivery Sales Market Share Forecast by Application (2016-2027)
Figure 24. Global Liposome Drug Delivery Revenue Market Share Forecast by Application (2016-2027)
Figure 25. Liposome Drug Delivery Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 26. North America Liposome Drug Delivery Revenue 2016-2027 (US$ Million)
Figure 27. North America Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Figure 28. North America Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Figure 29. Asia-Pacific Liposome Drug Delivery Revenue 2016-2027 (US$ Million)
Figure 30. Asia-Pacific Liposome Drug Delivery Sales Market Share by Region (2016-2027)
Figure 31. Asia-Pacific Liposome Drug Delivery Revenue Market Share by Region (2016-2027)
Figure 32. Asia-Pacific Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Figure 33. Asia-Pacific Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Figure 34. Europe Liposome Drug Delivery Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. Europe Liposome Drug Delivery Sales Market Share by Country (2016-2027)
Figure 36. Europe Liposome Drug Delivery Revenue Market Share by Country (2016-2027)
Figure 37. Europe Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Figure 38. Europe Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Figure 39. Latin America Liposome Drug Delivery Revenue Growth Rate 2016-2027 (US$ Million)
Figure 40. Latin America Liposome Drug Delivery Sales Market Share by Country (2016-2027)
Figure 41. Latin America Liposome Drug Delivery Revenue Market Share by Country (2016-2021)
Figure 42. Latin America Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Figure 43. Latin America Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Figure 44. Middle East and Africa Liposome Drug Delivery Revenue Growth Rate 2016-2027 (US$ Million)
Figure 45. Middle East and Africa Liposome Drug Delivery Sales Market Sha

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs